Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 323

    Money laundering case: ED custody of Sterling Biotechs director extended till Feb 7

    Money laundering case: ED custody of Sterling Biotech's director extended till Feb 7

    Ruby Khatun Khatun30 Jan 2018 10:15 AM IST
    New Delhi: A Delhi court has extended till February 7 the Enforcement Directorate custody of a director of a Gujarat-based pharma firm in a money...
    HealthCare at Home to hire around 4,500 persons in India by FY19-end

    HealthCare at Home to hire around 4,500 persons in India by FY19-end

    Ruby Khatun Khatun30 Jan 2018 10:00 AM IST
    New Delhi: Home healthcare service provider HealthCare at Home (HCAH) plans to hire around 4,500 employees by the end of next fiscal as it undertakes...
    AstraZeneca

    AstraZeneca's three in one inhaler helps COPD patients in trial

    Medical Dialogues Bureau30 Jan 2018 9:45 AM IST
    AstraZeneca said an inhaler for chronic obstructive pulmonary disease delivered improved lung function in a late-stage trial that could challenge...
    Abbott to take a pause after deal spree

    Abbott to take a pause after deal spree

    Medical Dialogues Bureau30 Jan 2018 9:30 AM IST
    Abbott Laboratories said it was not looking at acquisitions this year as the healthcare company looks to ease its debt burden after a spree of deals...
    Cipla gets USFDA approval for HIV drug

    Cipla gets USFDA approval for HIV drug

    Medical Dialogues Bureau29 Jan 2018 1:40 PM IST
    New Delhi: Drug major Cipla said it has received final approval from the US health regulator for tenofovir disoproxil fumarate tablets, used to treat...
    SMT announces positive results from the S flex UK Registry

    SMT announces positive results from the S flex UK Registry

    Ruby Khatun Khatun29 Jan 2018 10:15 AM IST
    Mumbai / London: SMT (Sahajanand Medical Technologies Pvt. Ltd.), India’s largest manufacturer of cardiovascular medical stents, announced the...
    Roche hemophilia drug lowers costs despite high price: ICER

    Roche hemophilia drug lowers costs despite high price: ICER

    Ruby Khatun Khatun29 Jan 2018 10:00 AM IST
    A costly new Roche Holding AG drug to treat the bleeding disorder hemophilia A could significantly reduce healthcare expenses for certain patients, a...
    EMA panel recommends Merck Pfizers diabetes drug

    EMA panel recommends Merck Pfizer's diabetes drug

    Medical Dialogues Bureau29 Jan 2018 9:45 AM IST
    A European Medicines Agency panel recommended granting marketing approval to a diabetes drug developed by Merck & Co and Pfizer Inc.The...
    AbbVie wins US trial in lawsuit over AndroGel

    AbbVie wins US trial in lawsuit over AndroGel's risks

    Medical Dialogues Bureau29 Jan 2018 9:30 AM IST
    A federal jury in Chicago found AbbVie Inc not liable in a lawsuit by an Arizona man who claimed he had suffered a pulmonary embolism due to using the...
    US SEC files suit over possible insider trading on Bioverativ

    US SEC files suit over possible insider trading on Bioverativ

    Medical Dialogues Bureau29 Jan 2018 9:15 AM IST
    The U.S. Securities and Exchange Commission filed an insider trading lawsuit on Friday against “unknown traders” who it said engaged in “highly...
    Ajanta Pharma Q3 net profit up 3 percent at Rs 147.47 crore

    Ajanta Pharma Q3 net profit up 3 percent at Rs 147.47 crore

    Medical Dialogues Bureau28 Jan 2018 11:00 AM IST
    New Delhi: Drug firm Ajanta Pharma reported a 3.41 percent rise in its consolidated net profit to Rs 147.47 crore for the quarter ended December 31,...
    Glenmark Pharma presents preliminary biomarker data on GBR 1302

    Glenmark Pharma presents preliminary biomarker data on GBR 1302

    Medical Dialogues Bureau28 Jan 2018 10:30 AM IST
    Mumbai: Pharma Major, Glenmark Pharmaceuticals announced a presentation of preliminary biomarker findings from a Phase 1 study of GBR 1302...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Government appoints 108 drug inspectors pan India; Details

    Government appoints 108 drug inspectors pan India; Details

    German drug assessment body not convinced by Bayers cancer drug Vitrakvi

    German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok